APA (7th ed.) Citation

Cohn, A., Morse, M. A., O'Neil, B., Whiting, S., Coeshott, C., Ferraro, J., . . . Rodell, T. C. (2018). Whole Recombinant Saccharomyces cerevisiae Yeast Expressing Ras Mutations as Treatment for Patients With Solid Tumors Bearing Ras Mutations: Results From a Phase 1 Trial. Journal of immunotherapy (1997), 41(3), 141. https://doi.org/10.1097/CJI.0000000000000219

Chicago Style (17th ed.) Citation

Cohn, Allen, Michael A. Morse, Bert O'Neil, Samuel Whiting, Claire Coeshott, John Ferraro, Donald Bellgrau, David Apelian, and Timothy C. Rodell. "Whole Recombinant Saccharomyces Cerevisiae Yeast Expressing Ras Mutations as Treatment for Patients With Solid Tumors Bearing Ras Mutations: Results From a Phase 1 Trial." Journal of Immunotherapy (1997) 41, no. 3 (2018): 141. https://doi.org/10.1097/CJI.0000000000000219.

MLA (9th ed.) Citation

Cohn, Allen, et al. "Whole Recombinant Saccharomyces Cerevisiae Yeast Expressing Ras Mutations as Treatment for Patients With Solid Tumors Bearing Ras Mutations: Results From a Phase 1 Trial." Journal of Immunotherapy (1997), vol. 41, no. 3, 2018, p. 141, https://doi.org/10.1097/CJI.0000000000000219.